Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice
- 17 July 2007
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 25 (36), 6604-6612
- https://doi.org/10.1016/j.vaccine.2007.06.058
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Dendritic cells as therapeutic vaccines against cancerNature Reviews Immunology, 2005
- Breast cancer vaccines: maximizing cancer treatment by tapping into host immunityEndocrine-Related Cancer, 2005
- The role of tumor stroma in the interaction between tumor and immune systemCurrent Opinion in Immunology, 2005
- Vaccination by Genetically Modified Dendritic Cells Expressing a TruncatedneuOncogene Prevents Development of Breast Cancer in Transgenic MiceCancer Research, 2004
- Cross-priming of CD8+ T cells stimulated by virus-induced type I interferonNature Immunology, 2003
- Viral infection switches non-plasmacytoid dendritic cells into high interferon producersNature, 2003
- Natural selection of tumor variants in the generation of “tumor escape” phenotypesNature Immunology, 2002
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Role of Alpha/Beta Interferon in Venezuelan Equine Encephalitis Virus Pathogenesis: Effect of an Attenuating Mutation in the 5′ Untranslated RegionJournal of Virology, 2001
- Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicityNature, 1979